Gemtuzumab Ozogamicin for Injection
Name: Gemtuzumab Ozogamicin for Injection
Indications
Newly-Diagnosed CD33-positive Acute Myeloid Leukemia (AML)
MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults.
Relapsed Or Refractory CD33-positive AML
MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older.
What happens if i miss a dose (mylotarg)?
Contact your doctor if you miss an appointment for your gemtuzumab injection.